Brief Prehabilitation Reduced Complications Prior to Gastrectomy
-
By
-
Kathryn Wighton
-
April 7, 2026
-
3 min
By
Kathryn Wighton
April 7, 2026
According to Agilent Technologies, the expanded indication covers esophageal and gastric tumor types and applies to patients being considered for nivolumab or nivolumab and hyaluronidase-nvhy.
July 14, 2026
Texas registry data point to neighborhood-level vulnerability as a possible target for improving timely colorectal cancer care.
June 12, 2026
A randomized trial found similar short-term morbidity and 12-month functional outcomes with both approaches, while highlighting the need to balance perfusion with a tension-free anastomosis.
July 15, 2026